Congressional Research Service Issues Insight White Paper on FDA Regulation of Blood & Blood Products
February 20, 2023
February 20, 2023
WASHINGTON, Feb. 20 -- The Congressional Research Service issued the following Insight white paper on the FDA regulation of blood and blood products (No. IN12108) on Feb. 13, 2023, by health policy analyst Jared S. Sussman:
* * *
FDA Regulation of Blood and Blood Products: Recent Draft Guidance on Donor Eligibility
The nation's blood supply is largely managed by a network of independent blood centers and the American Red Cross, with oversight from the . . .
* * *
FDA Regulation of Blood and Blood Products: Recent Draft Guidance on Donor Eligibility
The nation's blood supply is largely managed by a network of independent blood centers and the American Red Cross, with oversight from the . . .